Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline versus azithromycin with topical therapy in moderate acne vulgaris stratified by IL4 polymorphism
IRCT20230305057631N1Phase 2Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of doxycycline, azithromycin, benzoyl peroxide and tretinoin in acne vulgaris (2 arms), sponsored by Gonabad University of Medical Sciences. Primary endpoints: Acne severity, Recovery from the doctor's opinion and 1 more. Started Mar 2023; status: completed.
02
Drugs
doxycyclineazithromycinbenzoyl peroxidetretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20230305057631N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230305057631N1.